Retinopathy: An overlooked adverse effect of interferon-beta treatment of multiple sclerosis

Keio Journal of Medicine

Volumn 58, Issue 1, 2009, Pages 54-56

  Ohira, Masayuki ^a   Ito, Daisuke ^a   Shimizu, Toshihiko ^a   Shibata, Mamoru ^b   Ohde, Hisao ^a   Suzuki, Norihiro ^a  

^a KEIO UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

Author keywords

Adverse effect; Interferon; Multiple sclerosis; Retinopathy

Indexed keywords

AMLODIPINE BESYLATE; BETA INTERFERON; CANDESARTAN HEXETIL; VOGLIBOSE;

ADULT; ARTICLE; CASE REPORT; DIABETES MELLITUS; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERTENSION; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOSCOPY; PREVALENCE; RETINOPATHY; VISUAL FIELD DEFECT;

FEMALE; HUMANS; INTERFERON-BETA; MIDDLE AGED; MULTIPLE SCLEROSIS; RETINAL DISEASES;

EID: 65949086797     PISSN: 00229717     EISSN: 18801293     Source Type: Journal    
DOI: 10.2302/kjm.58.54     Document Type: Article

References (6)

1. Hayasaka S, Nagaki Y, Matsumoto M, Sato S: Interferon associated retinopathy. Br J Ophthalmol 1998; 82: 323-325 (Pubitemid 28177126)
2. d'Alteroche L, Majzoub S, Lecuyer AI, Delplace MP, Bacq Y: Ophthalmologic side effects during alpha-interferon therapy for viral hepatitis. J Hepatol 2006; 44: 56-61.
3. Sommer S, Sablon JC, Zaoui M, Rozot P, Hosni A. [Interferon beta-1b retinopathy during a treatment for multiple sclerosis]. J Fr Ophtalmol 2001; 24: 509-512
4. Longmuir R, Lee AG, Rouleau J: Cotton wool spots associated with interferon Beta-1 alpha therapy. Semin Ophthalmol 2007; 22: 49-53 (Pubitemid 46364762)
5. Mallada-Frechin J, Abellan-Miralles I, Alfaro-Beltra ML, Medrano V, Munoz-Gil MB, Fernandez-Izquierdo S, Piqueras-Rodriguez L: Retinopathy secondary to treatment with Interferon beta-1a in a patient with multiple sclerosis . Rev Neurol 2005; 40: 482-484 (Pubitemid 47233607)
6. Saito H, Suzuki M, Asakawa T, Kato S: Retinopathy in a multiple sclerosis patient undergoing interferon-therapy. Mult Scler 2007; 13: 939-940